First Affirmative Financial Network’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$587K Buy
+1,314
New +$613K 0.23% 101
2025
Q3
$397K Sell
1,015
-118
-10% -$49.3K 0.19% 137
2025
Q2
$504K Buy
1,133
+19
+2% +$8.76K 0.26% 104
2025
Q1
$540K Buy
1,114
+125
+13% +$58.3K 0.33% 84
2024
Q4
$398K Buy
989
+19
+2% +$8.81K 0.23% 119
2024
Q3
$451K Buy
970
+17
+2% +$8.17K 0.25% 113
2024
Q2
$447K Buy
953
+10
+1% +$4.34K 0.31% 93
2024
Q1
$394K Sell
943
-1
-0.1% -$423 0.29% 106
2023
Q4
$384K Buy
944
+208
+28% +$76.8K 0.31% 101
2023
Q3
$256K Buy
736
+132
+22% +$46.2K 0.25% 130
2023
Q2
$212K Buy
+604
New +$204K 0.21% 159

Other funds holding VRTX

First Affirmative Financial Network's VRTX Position: Q1 2026 in Review

First Affirmative Financial Network opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 1,314 shares worth $587K. The stake represents 0.23% of the portfolio and ranks #101 among its holdings. This is a return to the name: First Affirmative Financial Network previously reported a position in VRTX as recently as Q3 2025.

First Affirmative Financial Network first reported a position in VRTX in Q2 2023 and has held it in 11 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • First Affirmative Financial Network held 1,314 shares of Vertex Pharmaceuticals worth $587K as of Q1 2026.
  • Vertex Pharmaceuticals was a new First Affirmative Financial Network position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.23% of First Affirmative Financial Network's portfolio in Q1 2026, its #101 holding.
  • First Affirmative Financial Network first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on First Affirmative Financial Network's 13F filing for Q1 2026, filed 8 May 2026.